Fidelity Disruptive Medicine Fund
Limited financial coverage for FMEDX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The fund primarily directs at least 80% of its total assets into companies that are leading advancements in the medical sector. Its core investments largely consist of equity instruments. According to the Adviser, "disruptive medicine" companies encompass, but are not limited to, those engaged in fields such as robotic surgical procedures, gene therapy, genomic research, treatments for rare conditions, cutting-edge medical devices and apparatus, immunotherapy, digital healthcare platforms, and initiatives promoting consumer well-being.
- IPO
- 2020
- HQ
- Boston, MA, US
Get TickerSpark's AI analysis on FMEDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $11.60
- 52W Low
- $10.96
- 50D MA
- $11.34
- 200D MA
- $11.34
- Beta
- 0.78
- RSI (14)
- 53
- Avg Volume
- 0
No earnings-call transcripts are available for FMEDX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 3.83M
- Float Shares
- 0
Our FMEDX coverage
Recent articles, reports, and earnings notes.
No research on FMEDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FMEDX report →